| Host: |
HEK293 cells |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-Human IFN-alpha 2-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications. |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Endotoxin: |
Please contact us for more information. |
| Immunoreactivity: |
Measured by its binding ability in a functional ELISA. Immobilized Human IFNA2 at 2 Mu g/mL (100 Mu L/well) can bind Human IFNAR2 with a linear range of 0.2-617ng/mL.2. Recombinant human IFN-Alpha 2 (10 ng/mL) was used to treat HCT116 cells. Western- |
| Gene Symbol: |
IFNA2 |
| Gene ID: |
3440 |
| Uniprot ID: |
IFNA2_HUMAN |
| Immunogen: |
Recombinant Human IFN-alpha 2 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Cys24-Glu188) of human Interferon alpha 2/IFNA2 (Accession #NP_000596.2) fused with a 6×His tag at the C-terminus. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
